Postmarket Outcomes Study for Evaluation of the Superion™ Spacer

NCT ID: NCT04563793

Last Updated: 2025-01-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

129 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-08

Study Completion Date

2023-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this outcomes study is to compile real-world outcomes for the commercially approved Indirect Decompression Systems (IDS) in routine clinical practice when used according to the applicable Instructions for Use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Spinal Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Superion™ IDS

All patients to receive IDS for the treatment of their moderate Lumbar Spinal Stenosis Symptoms.

Superion™ IDS

Intervention Type DEVICE

All patients to receive IDS for the treatment of moderate Lumbar Spinal Stenosis symptoms.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Superion™ IDS

All patients to receive IDS for the treatment of moderate Lumbar Spinal Stenosis symptoms.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled to receive or previously received a commercially approved Boston Scientific Indirect Decompression Systems, per local Instructions for Use (IFU)
* Signed a valid, IRB approved informed consent form

Exclusion Criteria

* Meets any contraindication in BSC Indirect Decompression Systems local IFU
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natalie Bloom Lyons

Role: STUDY_DIRECTOR

Boston Scientific Corporation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pain Medicine Associates

Fountain Valley, California, United States

Site Status

California Orthopedics & Spine

Larkspur, California, United States

Site Status

Relieve Pain Center, Inc.

San Diego, California, United States

Site Status

Source Healthcare

Santa Monica, California, United States

Site Status

Pacific Research Institute

Santa Rosa, California, United States

Site Status

IPM Medical Group Inc

Walnut Creek, California, United States

Site Status

Holy Cross Hospital Inc.

Fort Lauderdale, Florida, United States

Site Status

Louis J. Raso, MD, PA

Jupiter, Florida, United States

Site Status

Florida Pain Institute

Merritt Island, Florida, United States

Site Status

Southwest Florida Pain Center

Port Charlotte, Florida, United States

Site Status

Georgia Pain and Spine Care, Inc.

Newnan, Georgia, United States

Site Status

Centurion Spine and Pain Centers

Waycross, Georgia, United States

Site Status

North Idaho Day Surgery LLC

Post Falls, Idaho, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

University of Kansas Hospital

Kansas City, Kansas, United States

Site Status

KC Pain Centers

Lee's Summit, Missouri, United States

Site Status

Comprehensive and Interventional Pain Management LLP

Henderson, Nevada, United States

Site Status

Premier Pain Center

Shrewsbury, New Jersey, United States

Site Status

University Clinical Research Center

Somerset, New Jersey, United States

Site Status

The Toledo Clinic

Toledo, Ohio, United States

Site Status

Center for Interventional Pain and Spine

Bryn Mawr, Pennsylvania, United States

Site Status

Advanced Spine Pain Solution

Laredo, Texas, United States

Site Status

Precision Spine Care

Tyler, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A4086

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prospective SPINE Registry
NCT04176562 RECRUITING
Spinal Cord Stimulation for Low Back Pain
NCT00205868 COMPLETED PHASE4